Philip Morris
Risk Assessment and Comparisons: An Introduction
Fields
- Author
- Crouch, Eac
- Wilson, R.
- Area
- LOGUE,MAYADA/OFFICE
- Type
- MAGA, MAGAZINE ARTICLE
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- BIBL, BIBLIOGRAPHY
- Site
- N426
- Request
- Stmn/R1-072
- Named Organization
- Centers for Disease Control
- Epa, Environmental Protection Agency
- FDA, Food and Drug Administration
- Epa, Environmental Protection Agency
- Named Person
- Cohen
- Document File
- 2025545619/2025546382/Harvard University Office of
- Continuing Education Short Course Program Harvard School
- of Public Health
- Continuing Education Short Course Program Harvard School
- Litigation
- Stmn/Produced
- Author (Organization)
- Harvard Univ Cambridge
- Science
- Master ID
- 2025545673/6381
Related Documents:- 2025545673-6381 Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025545684 Telephone Locations and Protocol
- 2025545689-5696 Risk Assessment for Carcinogens: A Comparison of Approaches of the Acgih and the Epa
- 2025545697 Hps Newsletter Interview with A Risk Expert
- 2025545698-5711 Science and Its Limits: the Regulator's Dilemma
- 2025545713-5721 Risk / Benefit Analysis
- 2025545722-5725 Risk Management Commentary for Dr. D. Allan Bromley Assistant to the President for Science and Technology
- 2025545750-5792 Risk Assessment of Chemical Carcinogens: Is It Time for A Change?
- 2025545795-5799 Tools of Risk Analysis Applications of Epidemiology
- 2025545800-5810 Notice of Intended Changes - Benzene
- 2025545811-5822 Epidemiology in Risk Assessment for Regulatory Policy
- 2025545824-5850 Risk Analysis in Environmental and Occupational Health Use of Animal and Other Data As Predictors of Human Risk
- 2025545851-5871 Risk Analysis in Environmental and Occupational Health Uncertainties in Predicting Human Risks
- 2025545872-5881 How Do Cancer Risks Predicted From Animal Bioassays Compare with the Epidemiologic Evidence? the Case of Ethylene Dibromide
- 2025545882-5887 Use of Biological Assays in Short-Term Assessment of Inhaled Substances
- 2025545888
- 2025545889-5891 Risk Analysis in Environmental and Occupational Health Are Your Mushrooms Safe to Eat?
- 2025545892-5899 the Rat As An Experimental Animal
- 2025545901-5907 Non-Cancer Endpoints
- 2025545910-5939 Cancer Facts & Figures - 890000
- 2025545940-5941 Cancer Facts & Figures - 890000
- 2025545942-5944 Get - the - Lead - Out Guru Challenged A Decade-Old Scientific Argument Over the Effects of Low-Level Lead on Iq Turns Nasty Following Allegations of Misconduct
- 2025545945-5948
- 2025545949-5958 the Question of Thresholds for Radiation and Chemical Carcinogenesis
- 2025545959-5980 Are There Thresholds for Carcinogenesis? the Thorny Problem of Low-Level Exposure
- 2025545981-5990 Perspectives on Comparing Risks of Environmental Carcinogens
- 2025545991-5998 Acceptable Cancer Risks: Probabilities and Beyond
- 2025546000-6011 Ideas in Pathology Pivotal Role of Increased Cell Proliferation in Human Carcinogenesis
- 2025546012-6017 Cell Proliferation in Carcinogenesis
- 2025546019-6027 the Role of Expert Judgement in Risk Analysis
- 2025546029-6039 the Respiratory Tract As A Route of Exposure
- 2025546040-6045 the Respiratory Tract As A Portal of Entry for Toxic Particles
- 2025546047-6062 Limitations to the Use of Employee Exposure Data on Air Contaminants in Epidemiologic Studies
- 2025546063-6083 Benefit - Cost Analysis of Environmental Regulation: Case Studies of Hazardous Air Pollutants
- 2025546086-6089 Legislative and Regulatory Aspects of Risk
- 2025546090-6099 Connecticut's Dioxin Ambient Air Quality Standard
- 2025546100-6103
- 2025546105 Annals of Radiation Calamity on Meadow Street
- 2025546106 Caution Urged When Using Insect Repellents
- 2025546116 Volatile Organics and Inorganics Action Levels 900400
- 2025546134-6135 Summary of Radon Test Results of the Household Testing Program
- 2025546141-6145 Introduction to Discussion Sessions
- 2025546146-6149 Risk Assessment in Environmental and Occupational Health Risk of Alar (Daminozide)
- 2025546150-6160 Intolerable Risk: Pesticides in Our Children's Food
- 2025546161-6162 Pesticides, Risk, and Applesauce
- 2025546163-6168 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546169 Daminozide / Udmh
- 2025546170-6172 the Relative Risk of Daminozide (Alar / Kylar) Use
- 2025546173 Be Most Wary of Nature's Own Pesticides
- 2025546174-6175 A Movie Star Pares the Apple Industry
- 2025546176-6183 Summary of Toxicology Data on Daminozide and Udmh
- 2025546184-6194 Attachment I Graphs of Data From NCI / Ntp 83 Daminozide
- 2025546195-6196
- 2025546197-6202 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546203-6224 Regulatory Decision - Making Under Uncertainty: the Case of Alar
- 2025546226 Epa Moves to Reassess the Risk of Dioxin Urged on by the Scientific Community, Epa Is Developing A New Model for Estimating Dioxin's Risk
- 2025546227 US Government Orders New Look at Dioxin the Environmental Protection Agency Is Evaluating Data From the Past Decade That Suggest Dioxin's Toxicity May Be Overestimated. A Risk Assessment Model Based on Biological Mechanism Is Being Drawn Up.
- 2025546228-6235 Dioxin Toxicity: New Studies Prompt Debate, Regulatory Action New Data on Dioxin's Effect on Humans, A Clearer Picture of the Cellular Events It Precipitates, and New Animal Toxicity Studies May Provide Epa with A Firm Basis for Regulation
- 2025546236-6250 the Regulation of Gene Expression by 2,3,7, 8-Tetrachlorodibenzo-P-Dioxin
- 2025546251-6253 Dioxin Risks Revisited Armed with A New Understanding of How Dioxin Works on the Molecular Level, A Number of Scientists Are Challenging Epa to Change the Way It Does Risk Assessment
- 2025546255-6258 Lead Toxicity Case Study for Short Course on Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025546259-6267 Lead
- 2025546268-6275 Lead in Bone: Implications for Toxicology During Pregnancy and Lactation
- 2025546276-6281 the Long-Term Effects of Exposure to Low Doses of Lead in Childhood An 11 - Year Follow-Up Report
- 2025546282-6285
- 2025546298-6321 Review 890000 Alice Hamilton Lecture Lead and Human Health:Background and Recent Findings
- 2025546323-6348 Traps and Errors in Risk Analysis
- 2025546349-6356 Health Risks the Perception of Reality and the Realty of Perception
- 2025546357-6362 Communicating Risk Under Title III of Sara: Strategies for Explaining Very Small Risks in A Community Context
- 2025546363-6368 Industrial Risk Perceptions
- 2025546369-6370 Too Many Rodent Carcinogens: Mitogenesis Increases Mutagenesis
- 2025546371-6373 Has Risk Assessment Become Too 'conservative'?
- 2025546374-6378 Health and Safety Risk Analyses: Information for Better Decisions
- 2025546379-6381 Telling Reporters About Risk Dealing with Reporters Needn't Be the Least Agreeable Part of the Job.
- Characteristic
- EXTR, EXTRA
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- zjp02a00
Document Images
Risk Assessment and Comparisons:
An Introduction
RICHARD WILSON AND E. A. C. CROUCH
Risk assessment is presented as a way of examining risks
so that they rnay be better avoided, reduced, or otherwise
managed. Risk implies uncertainty, so that risk assess-
ment is larg(.l;v concerned with uncertainty and hence
with a concept of probability that is hard to grasp. The
results of even the simplest risk assessments need to be
compared with similar assessments of commonplace situ-
ations to give them some meaning. We compare and
contrast some risk estimates to display their similarities
and differences,,
VERY DAY INE TAKE RISKS AND AVOID OTHERS. IT STARTS AS
soon as we wake up. One of us lives in an old house that had
old wiring. Each time he turned.on the light, there was a
small risk of electrocution. Every year about 200 people are
electrocuted in tlie United States in accidents involving home wiring
or appliances, repn:senting a risk of death of about 10-6 per year, or
7 x 10-' per iuf-time. To reduce this risk, he got the wiring
replaced. When we-wallc downstairs, we recall that 7000 people die
each vear in falls in U.S. homes. But most are over 65, so we pav
little attention to c`Lis risk since both of us are younger than that.
How should we go to work? Walking is probably safer than using
a bicvcle, but would take five times as long and provide less healthful
exercise. A car or, better, public transport would be both safer and
faster. Expediencv wins out, and the car comes out of the garage.
Fortunatelv, the c.hoice nowadays is not between horse or canoe-
both of which are much more dangerous. The day has just begun,
and already we are aware of several risks, and have made decisions
about them.
Most of us act semi-automatically to minimize our risks. We also
expect society to rniaimize the risks suffered by its members, subject
to overriding moral, economic, or other constraints. In some cases
these constraints will dominate, in others there will be trade-offs
between the values assigned to risks and the constraints. Risk
assessments, except in the simplest of circumstances, are not de-
signed for making judgments, but to illuminate them (1). To
effectivelv illuminate, and then to minimize, risks requires knowing
what they are and how big they are. This knowledge usually is
gained through experience, and the essence of risk assessment is the
application of this knowledge of past mistakes (and deliberate
actions) in an attempt to prevent new mistakes in new siruadons.
The results of risk a.ssessments will necessarily be in the form of an
estimate of probabilities for various events, usually injurious. The
goal in performing a risk assessment is to obtain such estimates,
although we consider the major value in performing a risk assess-
The authors are in the DcPartmcnt of Phvsics and the Energy and Environmental Poliey
Center, Harvard Universm, Cambridge, lAA 02138.
ment is the exercise itself, in which (ideally) all aspects of some
action are explored. The results, goals, and values of performing the
risk assessment must be sharply contrasted with the cultural values
assigned to the results. Such cultural alues will presumably be
factors influencing societal decisions and mav differ even for risk
estimates that are identical in probabilitv.
Risk and Uncertainty
The concept of risk and the notion of uncertainty are closely
related. We may say that the lifetime risk of cancer is 25%, meaning
that approximately 25% of all people develop cancer in their
lifetimes. Once an individual develops cancer, we can no longer talk
about the risk of cancer, for it is a certaintv. Similarlv if a man lies
dying after a car accident, the risk of his dving of cancer drops to
near zero. Thus estimates of risks, insofar as thev are expressions of
uncertainty, will change as knowledge improves.
Different uncertainties appear in risk estimation in different ways
(2). There is clearly a risk that an individual will be killed by a car if
that person walks blindfolded across a crowded street. One part of
this risk is stochastic; it depends on whether the individual steps off
the curb at the precise moment that a car arrives. Another part of the
risk might be systematic; it will depend on the nature of the fenders
and other features of the car. Similarly, if two people are both heavy
cigarette smokers, one may die of cancer and the other not; we
cannot tell in advance. However there is a systematic difference in
this respect between being, for instance, a heavy smoker and a
gluttonous eater of peanut butter, which contains aflatoxin. Al-
though aflatoxin is known to cause cancer (quite likely even in
humans), the risk of cancer from eating peanut butter is much lower
than that from smoking cigarettes. Exactly how much lower is
uncertain, but it is possible to make estimates of how much lower
and also to make estimates of how uncertain we are about the
difference.
Some estimates of uncertainties are subjective, with differences of
opinion arising because there is a disagreement among those
assessing the risks. Suppose one wishes to assess the risk (to
humans) of some new chemical being introduced into the environ-
ment, or of a new technology. Without any further information, all
we can say about any measure of the risk is that it lies between zero
and unity. Extreme opinions might be voiced; one person might say
that we should initially assume a risk of unity, because we do not
know that the chemical or technology is safe; another might take the
opposite extreme, and argue that we should initially assume that
there is zero risk, because'nothing has been proven dangerous. Here
and elsewhere, we argue that it is the task of the risk assessor to use
whatever information is available to obtain a number between zero
and one for a risk estimate, with as much precision as possible,
together with an estimate of the impre-ision. In this context, the
statement "I do not know" can be viewed only as procrastination
17 APRIL 1987 ARTICLES 267

and not responsive to the request for a risk estimate (although this
should not be re:ad as condemning procrastination in all circum-
stances).
The second extreme mentioned, the assumption of zero risk, can
arise because people and government agencies have a propensity to
ignore anything that is not a proven hazard. We argue that this
attitude is incon>istent if the objective is to improve the public
health, may also f.ead to economic inefficiencies, and often leads to
unnecessary contention between experts who disagree strongly.
Fortunately, if risk assessors have been diligent in searching out
hazards to assess, Few hazards posing large risks will be missed in this
wav, so that there may be minor direct danger to human health from
a continuation of the attitude.
Risk Estunxtion Based on Historical Data
The way in which risks are perceived is strongly correlated with
the way in which they are calculated. Risks based on historical data
are particularly casv to understand and are often perceived reliably.
It is therefore easv to illustrate a risk calculated from historical data
to understand some characteristics of risk estimation. There are
plenty of data on automobile accidents (although never enough to
make risk assessors happy). One thing that these data can tell us is
the frequency oE such accidents in the past and their trend through
time. To make p;redictions, however, we must use a model. The
simplest model is that there will be as many accidents next year as
last, to within a statistical error of the square root of the number. A
slightly more complicated, but perhaps more accurate, model might
be to fit a mathernatical funcrion to numbers from previous years
and to argue that next year's accidents will follow the trend given by
this function. A possibly better and possibly more accurate model
still might use all available information that might influence accident
trends. For exaniple, an oil embargo with a concomitant rise in oil
price and reduction in automobile travel would be likely to reduce
the risk of accid:nt. In anv event, it becomes clear that it is
impossible to calculate anv risk without a model of some sort, even
the simple one that tomorrow will be like today.
Risks of New Technologies
We can only usc: the historical approach to estimating risks when
the hazard (for example, technology, chemical, or simply some
action) has been present for some time and the risk is large enough
to be directly measured (although when it is not large enough to be
Table 1. Comparison of several common radiation risks.
Cancers if all
Dose
S
population
U
ttion
A (mrem/ .
.
.
year) exposed
(assuming linearity)
Medical x-rays 40 1100
Radon gas (1.5 pCiLliter, equivalent
dose)* 500 13,500
Potassium in own bodv 30 1000
Cosmic radiation at sea level 40 1100
Cosmic radiation at Denver 65 1800
Dose to average resident near
C.hemobvl first year 5000 Not relevant
One traziscontinental round trip by air 5 135
Average within 20 miles of nuclear plant 0.02 > 1
*The radon exposure is to the lungs and cannot be directiv compared to whole body
external exposure. The comparison here is on the basis of thc same magnitude of risk.
The uncertamtv of the radon number is at least a factor of 3.
268
Table 2. Some commonplace risks (mean values with uncertainty).
Action Annual risk Uncertainn,
Motor vehicle accident (total) 2.4 x 10-4 10%
Motor vehicle accident
(pedestrian only) 4.2 x 10-5 10%
Home accidents 1.1 x 10-4 5%
Electrocution 5.3 x 10-6 5%
Air pollution, eastern United States 2 x 10-4 Factor of 20
downward onlv
Cigarette smoking, one pack per day 3.6 x 10' Factor of 3
Sea-level background radiation
(except radon) 2 x 10-5 Factor of 3
All cancers 2.8 x 10-i 10%
Four tablespoons peanut butter per day 8 x 10-6 Factor of 3
Drinking water with EPA limit of
chloroform 6 x 10' Factor of 10
Drinking water with EPA limit of
trichloroethylene 2 x 10-9 Factor of 10
Alcohol, light drinker 2 x 10-5 Factor of 10
Police killed in line of dutv (total) 2.2 x 10-4 20%
Police killed in line of dutny (by felons) 1.3 x 10-4 10%
Frequent fiying professor 5 x 10-5 50%
Mountaineering (mountaineers) 6 x 10-x 50%
measured, an upper limit may be calculated, if one assumes some
sort of model). If there is no historical database for the hazard (a
new power plant or industrial facilitv, for instance), one approach is
to consider it in separate parts, calculating the risks from each part
and adding them together to estimate a risk for the whole. For
example, all possible chains of events from an initiator to a final
accident are followed in an "event tree," with the probabilities of
each event in the tree being estimated from historical data in
different situations.
A particularly well-known example is the calculation of the
probabilitv of a severe accident at a nuclear power plant (3). That
this procedure has at least a partial validity is due to the fact that the
design of nuclear power plants proceeded in approximately this
factorable way; attempts were made to imagine all major accident
possibilities, "maximum credible accidents" or "design basis acci-
dents," and then to add an independent device to prevent this
accident from having severe consequences. To the extent that the
added safetv device is independent, the failure probability is inde-
pendent, and the small overall accident probability is the product of
individual failure probabilities which are larger.
Risks by Analogy: Carcinogenic Risks
Some carcinogenic risks may be estimated from historical data.
But this is complicated by the time delay between the insult and the
final cancer, one reason why causality is hard to prove if the risk is
small. This is the difficult field of epidemiology.
Although some of the largest cancer risks have been identified
through the use of epidemiology (4), preventive public health
suggests that we endeavor to estimate risks even where no historical
data exist and the risk is small. This is often done by analogy with
the cancer risks to animals, usually rodents, which are deliberately
exposed to large enough quantities of pollutant so that an effect is
observed. To use these data to estimate the risk at low doses in
people involves (to oversimplify matters) two difficult steps: the
comparison of carcinogenic potency in animal and man (5-7) and
the extrapolation from a high dose to a low dose. Because both steps
require a certain amount of theory, they are controversial. Indeed,
there are those who regard the uncertainty as so great that the}
prefer not to provide numerical estimates of risk (8, 9), although
they may order materials in carcinogenic.potenc,v. The difference
SCIENCE, VOL. 236

between this and providing a numerical estimate is important, but is
one of presentation rather than substance.
If there are no animal data, or if in an animal experiment there is
no statistically siiplificant effect, it does not necessarily mean that
there is no risk. If the experimenters have been diligent, the risk is
probably small, ai:though never zero, even though that may be the
best estimate. Various attempts are made to use data even less direct
than the animal bioassavs to estimate risks in such cases. These
include simple analogies based on chemical similarity (10), and
comparison witC1 outcomes other than cancer-for example, muta-
genesis (11) and acute toxicity (12, 13). Not surprisingly, these
more indirect procedures arouse even more controversy than the
animal bioassavs.
There have been few attempts to perform risk assessments for
biological end points other than cancer. However, it is known that
the pollutants in cigarette smoke cause at least as many deaths
through heart problems as bv cancer (14), and we should not be
surprised if other carcinogens were to produce chronic effects other
than cancer. For now, the cancer risk assessment has to act as
surrogate for these other risks also.
Risk Value Versus Certainty of Information
After risks of a number of situations have been assessed, we often
want to order them in order to decide which should command our
attention. It is not alwavs the order of increasing risk that is used for
such purposes. There have been proposals to order potential
carcinogens on other factors (8, 15), such as the certainty of
information.
Vinyl chloride gas has been found to cause angiosarcomas both in
people and in rats. Since an angiosarcoma is a rare tumor, the risk
ratio (the ratio oEthe observed number of cancers in those exposed
to the number expected by chance) is of order 100 or more in some
cases. If an angiosarcoma is seen in a vinyl chloride worker, the
attribution to vinvl chloride exposure is almost certain. On the other
hand, the number af persons who have been heavily exposed to vinyl
chloride is small, so that only about 125 angiosarcomas have been
seen among vinyl chloride workers worldwide in the last 20 years.
Now that exposure; in the workplace have been greatly reduced, no
angiosarcomas attributable to recent occupational exposure have
been seen. We do not know the dose-response relation, but it is
generally believed that the response falls at least linearly as the
exposure is reduced, so that no more than one cancer is expected in
several years.
We can compare this with the possible cancer incidence that was
predicted by the Food and Drug Administration (FDA) in 1977
from use of saccharin (16). This was based on experiments with rats,
leading to an additional uncertainty. More people ate saccharin than
were exposed to vim11 chloride, and nearly 500 cancers per year were
estimated for the United States alone. For vinyl chloride we
therefore have the s:ituarion that the individual risk is now low, yet
there is considerable certainty that there is a risk. For saccharin the
risk is higher, but there is more uncertainty about the value of the
risk. Some persons, in some situations, may demand that more
attention be given. to the risk from vinyl chloride than to the risk
from saccharin; for other persons or situations the reverse may be
the case.
Comparison of Risks
The purpose of risk assessment is to be useful in making decisions
about the hazards causing risks, and so it is important to gain some
I'7 APRIL 1987
perspective about the meaning of the magnitude of the risk.
Comparisons can be useful. We are not born with an instinctive
feeling for what a risk of one in a million per lifetime means,
although we do learn that some risks are small and others large. It is
particularly helpful to compare risks that are calculated in a similar
way. For example, the risk of traveling by automobile can be compared
to that of traveling by horse with the use of historical data.
Another common procedure is to compare exposures only. Table
1 shows a list of radiation exposures in typical situations (17). The
dose-response relation for radiations with similar energy deposition
per unit track length will be similar, although there may be some
correction required for dose-rate effects, so that ordering by expo-
sure should be similar to ordering by risk. In estimating the number
of lethal cancers on a linear hypothesis, we have here assumed
approximately 8000 man-rems per cancer (at low doses), in itself
uncertain by 30% or more.
, An example of comparison of risks that are similarly calculated is
the'comparison of risks of various chlorinated hvdrocarbons in
drinking water. The risks to humans are estimated from carcinogen
bioassavs in rodents (rats and mice). Since these are similar materi-
als, we might expect that the dose-response relationships have the
same shape. Chloroform, which is produced by interaction of
chlorine with organic matter during the chlorination of surface
waters to kill bacteria, produces cancer in animals 20 times as readilv
as does trichloroethvlene, an industrial solvent that is occasionallv
found in well waters as a result of accidental pollution. Although
neither is known to cause cancer in people, we might expect that
chloroform would do so about 20 times as readily.
Table 2 shows a variety of risks calculated in various ways and our
estimate of the uncertainty. They are deliberately jumbled to
provoke thought by juxtaposition. [Risk estimates quoted by the
Environmental Protection Agency (EPA) for carcinogens tend to be
greater than those shown in- Table 2 by a factor approximately equal
to the uncertaintv factor-this is not accidental (5, 18).l
Contrasting Risks
Objections have been raised to risk comparisons on the ground
that they are misleading. This would be true if all risks of the same
numerical magnitude were treated in the same way. But they are not.
In some cases it is useful to contrast risks to indicate the different
ways in which they are treated in society. In Table 3 we give an
example by comparing and contrasting the carcinogenic effects of
aflatoxin B 1 and dioxin, both among the most carcinogenic chemi-
cals known. The difference in treatment of these two materials is
perhaps a reflection of different values assigned to various aspects of
the problems caused by their presence.
Aflatoxin and dioxin have similar toxicities and carcinogenic
potency (perhaps within a factor of 10, although both measures for
both chemicals van substantially with species tested). The certainty
of information for aflatoxin is great There is less information about
carcinogenicitv of dioxin. Dioxin may be a promoter and pose a
minuscule risk at low doses, whereas aflatoxin is almost certainly an
initiator also. Nonetheless such standards as there are appear to be
more stringent for dioxin, possibly because dioxin is an artificial
chemical and possibly because it was a trace component of a
chemical mixture (Agent Orange) that was used in warfare.
The small risk of a large accident in a nuclear power plant can also
be contrasted with the more numerous small accidents or events that
occur every day in the mining, transport, and burning of coal. One
feature that is brought out dearly here is that we do not always
compare the risk averaged over time, but worry more about risks
that are sharply peaked in time.
ARTICLES 269 ,

Expression of Risks
Jusr as a comparison of risks is an aid in understanding them, so is
a careful selection of the methods of expression. It is hard to
comprehend the statistical (stochastic) nature of risk. There are ways
to mitigate this difficulty in comprehension. We are almost all used
to one such statistical concept the expectation of life. When we talk
about the expectar.on of life being 79 years (for a nonsmoking male
in the United Stares) we all know that some die young and that
many live to be over 80. Thus the expression of a risk as the
reduction of life expectancy caused by the risky action conveys some
of the statistical concept essential to its understanding. One particu-
lar calculation of th is type can be used as an anchor for many people,
because it is easy to remember. The reduction of life expectancy by
smoking cigarettes can be calculated from the risk, one in 2 million,
of smoking one cigarette, multiplied by the difference of the average
life-span of a nonsrnoker and a lung cancer victim. This turns out to
be 5 minutes, or the time it takes to smoke the one cigarette.
It is important ro realize that risks appear to be very different
when expressed in different ways (19). One example of this can be
seen if we consider the cancer risk to those persons exposed to
radionuclides after the Chernobvl disaster. According to the Soviets
(20), the 24,000 persons between 3 and 15 kilometers from the
plant, but excluding the town of Pripyat, received and are expected
to receive 1.05 million man-rems total integrated dose, or about 44
Table 3. Comparison of two very touc chemicals, afiatoxin Bl (22) and
dioxin (23); CDC, Centers for Disease Control.
Measure Aflatoxin B1 Dioxin
Acute toxicity High Equal
Carcinogenic potency to people -500 Unknown
[(kg dav)/mg]
Carcinogenic potency to rats -5000 -5000
[(kg dav)/mg]
Mutagenic Yes No
Certaintv of information on human High Low
carcinogenicitv
Activin, (initiator or promoter) Initiator Promoter (?)
Possibilitt of threshold dose response Low High
Source Natural Artificial
Common knowledge Little known Agent Orange
FDA action level in peanuts (ppb) 20
CDC level of concem in soil (ppb) 1
on waste disposal. Economists and others often argue that efficiency
depends on adjusting society until the amounts spent to save lives in
different situations are equalized. It seems to us that society does not
work that way. People are aware of the order of magnitude of these
differences, and approve of them. Nonetheless, we believe that
providing this information to a decision-maker is essential for an
informed decision.
rems average. Even if we assume a linear dose-response relation,
with 8000 man-rems per cancer, the risk may be expressed in
different wavs. Dividing 1.05 million man-rems by 8000 gives 131
cancers expected in the lifetimes of that population. This is larger
than, and for some people more alarming than, the 31 people within
the power plant itself who died within 60 days of acute radiation
sickness combined with burns. Dividing the 131 again by the
approximately 5000 cancer deaths expected from other causes, the
accident caused "ordy" a 2.6% increase in cancer. This seems small
compared to the 30% of cancers attributable to cigarette smoking.
The difference is even more striking if we consider the 75 million
people in Bvelorussia and the Ukraine who received, and will
receive, 29 million. man-rems over their lifetimes. On the linear dose-
response relation this leads to 3500 "extra cancers," surelv a large
number for one accident. But dividing by the 15 million cancers
expected in this population leads to an"insignificant" increase of
0.0 a 3%. Of course:, none of the methods of expressing the risk can
be considered "right" in an absolute sense. Indeed, it is our belief
that a full undersrnding of the risk involves expressing it in as many
diffierent ways as possible.
Cost of Reducing a Risk
Another interesiarlg and instructive way of comparing risks is by
comparing the amount people have paid in the past to reduce them.
It might be thought that people would try to adjust their activities
until the amount spent is roughly the same. Cohen (21) has shown
that the amounts sp ent vary by a factor of more than a million. He
shows that it would be possible even for an American to save lives in
Indonesia by aiding in immunization at $100 per life saved. Society
is willing to spend :more on environmental protection to prevent
cancer (over $1 m:ill:ion per life) than on cures (about $50,000 per
life with the high value of $200,000 for kidney dialysis raising some
objections). This ratio is in rough accord with the maxim "an ounce
of protection is bexer than a pound of cure." Z'eople are willing to
spend still more on radiation protection at nuclear power plants and
REFERENCES AND NOTES
1. L. B. Lave, Sci'ence 236. 291 (1987).
2. R. Wilson, E. A. C. Crouch, L. Zeise, in Risk Quanritation and Requlatorv Policy
(Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY,1985), Banbury
Repon, vol. 19, pp. 133-147.
3. N. C. Rasmussen er al., "Reactor safetv studv-an assessment of accident risks in
U.S. commercial nuclear power plants" (WASH 1400. \'UREG 75/014, U.S.
Nuclear Re¢ulatorv Commission, Washington, DC, 1975). See also D. Okrent.
Science 236,296 (1987).
4. R. Doll and R. Peto, J. Nat1. Cancer Imt. 66, 1191 (1984).
5. E. L. Anderson et al., Rirk Arurl. 3, 277 (1983).
6. E. A. C. Crouch and R. Wilson, J Taxical. Enriron. Health 5, 1095 (1979).
7. E. J. Calabrese, Principles ofAnimal Extrapolation (Wilev, New York, 1983).
8. R. Peto, inAssesanent ofRlsk from Low-Lcrrl Erporure to ftadiation and Chemualt, A.
D. Woodhead, C. J. Shellabarger, V. Pond, A. Hollaender, Eds. (Plenum, New
York, 1985), pp. 3-16.
9. B. N. rlmes, R. Magaw, L. S. Gold, Scicnce 236, 271 (1987).
10. "Control of trihalomethanes in drinking water." proposed rule. Fed. Reqirr. 43.
5756 (1968). See also the advanced notice [ibid. 41. 28991 (1976)] and the final
rule [ibid. 44, 68624 (1979)].
11. M. MeseLson and K. Russell- in rns of Human Canca. H. H. Hiatt, J. D.
Watson, J. A. Winstcn. Eds. (Col Spring Harbor Laboraton', Cold Spring
Harbor, ; 7Y, 1977) p. 1473.
12. S. Parodi, M. Tamngher, P. Boero, L. Santi, Mutat. Res. 93, 1(1982).
13. L. Zeise, R. Wilson, E. A. C. Crouch, RirkAnal. 4, 187 (1984).
14. Smoking and Health, a Report oftheSurgeon General (PHS79-50066, Public Health
Service, Washington, DC, 1979).
15. R A. Squire, Scrcnu 214, 877 (1981).
16. "Sacchann and its salts," proposed rule and hearing, Fed. Regict. 42, 19996 (1977).
17. R. Wilson and W. J. Jones, E~scr,~y Ecok~tv and theEnrironmenr (Academic Press,
New York, 1974), table 9-6. Other entnes mav be readilv calculated from data in
the reports of the United Nations scientific committec on the effects of atomic
radiation ["Sources and effects of ionizing radiation" (United Nations, New York,
1977)] and the report of the Committee on the Biological Effects of Ionizing
Radiations ["The effects on populations of exposure to low levels of ionizing
radiations" (National Acadcmy Press, Washington. DC, 1980)].
18. M. Russcll and M. Gruber, Scicncc 236, 286 (1987).
19. A. Tverskv and D. Kahneman, ibid. 211, 453 (1981). See also P. Slovic, ibid. 236,
280 (1987).
20. L'.S.S.R State Committee for the Utilization of Atomic Energy, `°Che accident at
the Chernobvl Nuclear Power Plant and its consequences," working document for
the Post Accident Review Meeting, 25-29 August 1986, International Atomic
Encrgq Agency, Vienna.
21. B. L. Cohen,'Healrh P{m. 38, 33 (1980).
22. H. R. Roberts, "The regulatory outlook for nut produczs," paper presented at the
Annual Convention of the Peanut Butter Manufacturers and Nut Salters Associa-
don, West Palm Beach. FL, November 1977.
23. R. D. Kimbrough, H. Falk, P. Stehr, G. Fries, J. Taritol. Environ. Health 14, 47
(1984).
24. Our work on risk assessment has been supported by donations from Clairol, Inc.,
the Dow Chemical Company, the Cabot Corporation, the General Electric
Foundation, and the Monsanto Corporation. .
270 SCIENCE, VOL. 236
